Fuzhegn Nizeng Formula for Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia, a Multicenter Randomized Controlled Trial
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Fuzheng Nizeng Formula (FZNZ) is derived from the classic formula Liujunzi Decoction. Former pilot study found that FZNZ promoted the recovery of gastric atrophy and relieve the relative symptoms. This study is to evaluate its efficacy for chronic atrophic gastritis with low-grade intraepithelial neoplasia, compared with positive control Molduodan granule.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia diagnosed by endoscopy and stomach biopsy.
• Helicobacter pylori negative.
• TCM syndrome is spleen-stomach deficiency with blood stasis and phelgm.
Locations
Other Locations
China
Peking University First Hospital
RECRUITING
Beijing
Time Frame
Start Date: 2022-10-24
Estimated Completion Date: 2024-12-31
Participants
Target number of participants: 144
Treatments
Experimental: Fuzhegn Nizeng Formula
Active_comparator: Moluodan patient medicine
Related Therapeutic Areas
Sponsors
Leads: Peking University First Hospital